AQP4 and neuromyelitis optica: A major discovery in demyelinating disorders was when Hinson et al. [77–79] discovered a potential pathogenic immunoglobulin G binding to the extracellular domain of a water channel aquaporin-4 (AQP4) in patients with neuromyelitis optica (NMO).